Skip to content

Transradial Access in Peripheral Vascular Interventions

Transradial Access in Peripheral Vascular Interventions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034564
Enrollment
25
Registered
2025-06-18
Start date
2025-02-05
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I70.2

Interventions

Group 1: All PAD patients >18 Jahre who receive a PTA of the iliac arteries will be asked to participate in the clinical trial. If the patient decides to participate in the study after the medical con

Sponsors

Elblandklinikum Radebeul
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients > 18 years 2. Patient has been informed about the type of study, duration and follow-up examination and has signed the informed consent 3. Reference vessel diameter (RVD) of the radial artery suitable for 6F access (sonographically determined) 4. Openness of the radial artery and ulnar artery (sonographically determined) 5. De-novo or restenotic lesion with > 70% stenosis (as assessed by the examiner) of the iliac arteries 6. Lesion is suitable for PTA or stenting 7. Rutherford Category 2-6

Exclusion criteria

Exclusion criteria: 1. Patients < 18 years 2. Participation in another drug, medical device or biological study 3. Acute vascular occlusions 4. Acute myocardial infarction < 30 days before the index procedure 5. Acute stroke < 30 days before the index procedure 6. Pregnant or breastfeeding patients 7. Life expectancy < 1 year 8. Patients with previous aortic arch embolisms or aortic arch procedures 9. Patients with sonographically confirmed occlusion of the radial artery or ulnar artery 10. Aneurysms in the target vessel 11. ASA/clopidogrel intolerance 12. Rutherford Category 0-1

Design outcomes

Primary

MeasureTime frame
Primarily transradial technical success: - successful intervention with balloon/stent with < 30% residual stenosis (according to visual assessment of the examiner) - Frequency of access route changes

Secondary

MeasureTime frame
Complications at the puncture site (24h and 1 month post-interventional): - Bleeding, pseudoaneurysms, arteriovenous fistulas, radial ruptures or occlusions Absence of stroke and procedure-related death (30 days) Duration of intervention Fluoroscopy time Length of hospital stay Cost of the intervention Improvement of subjective quality of life compared to Baseline and follow-up using the Vascular Quality of Life Questionnaire (VascuQoL-6) Change in subjective pain perception before and after Procedure using Numeric Rating Scale (NRS)

Countries

Germany

Contacts

Public ContactTorsten Fuß

Elblandklinikum Radebeul

Marie.Koch@elblandkliniken.de+493518334626

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026